What this means
This trial is looking at why older adults on chemotherapy may get dizzy or walk less well. It also tests whether a health check and group exercise can help.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 65 and over · Older adults aged 65 and up with colorectal cancer, not yet reported
- Where
- 2 sites
The science
- Registered title
- The SaVe Project-Sarcopenia and Vertigo in Aging Patients With Colorectal Cancer
- Trial ID
- NCT05710809 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Colorectal Cancer, Oncologic Complications, Comprehensive Geriatric Assessment, Vestibular Rehabilitation, Geriatric Oncology, Sarcopenia, Vertigo, Cancer, Rehabilitation, Exercise, Geriatric, Elderly, Frail, Older Adults, Chemotherapy, Chemotherapy-induced Peripheral Neuropathy, Resistance Training, Balance Training, Postural Stability, Pragmatic Trial, Personal Medicine, Individualised
- What is tested
- Targeted specialized physical group-based exercise and Comprehensive Geriatric Assessement
- Sponsor
- Copenhagen University Hospital, Rigshospitalet
- Ages
- 65 Years to no maximum
- Dates
- First posted Feb 2, 2023 · updated Apr 6, 2025
Registry summary
The goal of this clinical trial is to learn about the cause of dizziness and decline in walking ability in in older adults ≥65 years during chemotherapy treatment for colorectal cancer. Another goal is to investigate if a comprehensive geriatric assessment and three months' specialized physical group-based exercise three times/week can counteract muscle weakness, vertigo, instability, impaired walking balance, and neuropathy
Sites (2)
- Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
- Copenhagen University Hospital - Herlev and Gentofte Hospital, Herlev, Denmark